Nuclear factor kappa-B and the heart
- PMID: 11499717
- DOI: 10.1016/s0735-1097(01)01377-8
Nuclear factor kappa-B and the heart
Abstract
Nuclear factor kappa-B (NFkappaB), a redox-sensitive transcription factor regulating a battery of inflammatory genes, has been indicated to play a role in the development of numerous pathological states. Activation of NFkappaB induces gene programs leading to transcription of factors that promote inflammation, such as leukocyte adhesion molecules, cytokines, and chemokines, although some few substances with possible anti-inflammatory effects are also NFkappaB regulated. The present article reviews basic regulation of NFkappaB and its activation, cell biological effects of NFkappaB activation and the role of NFkappaB in apoptosis. Evidence involving NFkappaB as a key factor in the pathophysiology of ischemia-reperfusion injury and heart failure is discussed. Although activation of NFkappaB induces pro-inflammatory genes, it has lately been indicated that the transcription factor is involved in the signaling of endogenous myocardial protection evoked by ischemic preconditioning. A possible role of NFkappaB in the development of atherosclerosis and unstable coronary syndromes is discussed. Nuclear factor kappa-B may be a new therapeutic target for myocardial protection.
Similar articles
-
Signal transduction through nuclear factor kappa B in ischemia-reperfusion and heart failure.Basic Res Cardiol. 2004 Jan;99(1):1-7. doi: 10.1007/s00395-003-0442-7. Epub 2003 Oct 30. Basic Res Cardiol. 2004. PMID: 14685699 Review.
-
Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia-inducible factor 1 alpha in the heart.Eur J Cardiothorac Surg. 2008 Nov;34(5):976-84. doi: 10.1016/j.ejcts.2008.07.066. Epub 2008 Oct 7. Eur J Cardiothorac Surg. 2008. PMID: 18842422 Clinical Trial.
-
Myocardial protection by remote preconditioning: the role of nuclear factor kappa-B p105 and inducible nitric oxide synthase.Eur J Cardiothorac Surg. 2004 Nov;26(5):968-73. doi: 10.1016/j.ejcts.2004.06.015. Eur J Cardiothorac Surg. 2004. PMID: 15519191
-
[Clinical value of some factors of gene transcription in heart diseases].Kardiologiia. 2004;44(1):66-70. Kardiologiia. 2004. PMID: 15029150 Review. Russian.
-
A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NFkappaB binding site: evidence for a role of NFkappaB in ischemia-reperfusion injury.Circulation. 1997 Nov 4;96(9 Suppl):II-280-4; discussion II-285. Circulation. 1997. PMID: 9386111
Cited by
-
M3 subtype of muscarinic acetylcholine receptor promotes cardioprotection via the suppression of miR-376b-5p.PLoS One. 2012;7(3):e32571. doi: 10.1371/journal.pone.0032571. Epub 2012 Mar 2. PLoS One. 2012. PMID: 22396777 Free PMC article.
-
Cardioprotective effects of Guanxinshutong (GXST) against myocardial ischemia/ reperfusion injury in rats.J Geriatr Cardiol. 2012 Jun;9(2):130-6. doi: 10.3724/SP.J.1263.2011.11261. J Geriatr Cardiol. 2012. PMID: 22916058 Free PMC article.
-
Quercetin reduces inflammatory responses in LPS-stimulated cardiomyoblasts.Oxid Med Cell Longev. 2012;2012:837104. doi: 10.1155/2012/837104. Epub 2012 May 22. Oxid Med Cell Longev. 2012. PMID: 22685622 Free PMC article.
-
NF-kappaB as a molecular link between psychosocial stress and organ dysfunction.Pediatr Nephrol. 2004 Nov;19(11):1189-91. doi: 10.1007/s00467-004-1603-0. Epub 2004 Aug 20. Pediatr Nephrol. 2004. PMID: 15322889
-
Systemic inflammation in heart failure--the whys and wherefores.Heart Fail Rev. 2006 Mar;11(1):83-92. doi: 10.1007/s10741-006-9196-2. Heart Fail Rev. 2006. PMID: 16819581 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
